Quest Laboratories Limited (NSE:QUESTLAB)

India · Delayed Price · Currency is INR

90.00

+3.70 (4.29%)

Nov 11, 2026, 1:04 PM IST

Market Cap	1.47B +2.3%
Revenue (ttm)	1.12B +7.6%
Net Income	148.71M +8.5%
EPS	9.07 +8.4%
Shares Out	16.39M
PE Ratio	9.92
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,000
Open	91.90
Previous Close	86.30
Day's Range	90.00 - 92.00
52-Week Range	68.60 - 152.60
Beta	1.02
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Quest Laboratories

Quest Laboratories Limited manufactures and sells pharmaceutical formulations in India. The company offers ethical drugs, generic drugs, and over the-counter drugs under various categories, such as antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and others. It provides products in various forms, such as tablets, liquid orals, oral dry powders, oral powders, ointments, external liquids, and oral suspension. The company also engages in PCD and contract ma... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 1994

Employees 99

Stock Exchange National Stock Exchange of India

Ticker Symbol QUESTLAB

Full Company Profile

Financial Performance

In fiscal year 2026, Quest Laboratories's revenue was 1.12 billion, an increase of 7.56% compared to the previous year's 1.04 billion. Earnings were 148.71 million, an increase of 8.45%.

Financial Statements